© 2021 MJH Life Sciences and Pharmacy Times. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmacy Times. All rights reserved.
March 03, 2020
Peer-reviewed research conducted by the National Pharmaceutical Council (NPC) and the Center for the Evaluation of Value and Risk in Health at Tufts Medical Center over the past 2 years sheds some light on what’s behind discrepancies in coverage decisions from one insurer to the next.
October 23, 2019
Fortunately, there is good news for patients with chronic conditions and who are in a high-deductible health plan.
September 26, 2019
Value assessment frameworks are expected to play a more pivotal role in decisions that affect future patient choice and access.
July 22, 2019
States are getting inventive in their approaches to meeting the health care needs of their citizens, especially when it comes to curative treatments for conditions that have a high prevalence rate.